165 related articles for article (PubMed ID: 7945541)
1. 1'-Hydroxyeugenol- and coniferyl alcohol derivatives as effective inhibitors of 5-lipoxygenase and Cu(2+)-mediated low density lipoprotein oxidation. Evidence for a dual mechanism.
Deigner HP; Wolf G; Ohlenmacher U; Reichling J
Arzneimittelforschung; 1994 Aug; 44(8):956-61. PubMed ID: 7945541
[TBL] [Abstract][Full Text] [Related]
2. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
3. 5-Lipoxygenase inhibitory and antihistamine activities of linetastine.
Shizawa T; Ohmori S; Maeda K; Sakata K; Ishii T; Kamitani T
Arzneimittelforschung; 1996 Nov; 46(11):1072-6. PubMed ID: 8955867
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors.
Sadeghian H; Seyedi SM; Saberi MR; Arghiani Z; Riazi M
Bioorg Med Chem; 2008 Jan; 16(2):890-901. PubMed ID: 17998164
[TBL] [Abstract][Full Text] [Related]
5. 6-substituted purines as inhibitors of 15-lipoxygenase; a structure-activity study.
Bråthe A; Gundersen LL; Malterud KE; Rise F
Arch Pharm (Weinheim); 2005 Apr; 338(4):159-66. PubMed ID: 15864785
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
Gupta N; Nicholson DW; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
[TBL] [Abstract][Full Text] [Related]
7. Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast.
Ramires R; Caiaffa MF; Tursi A; Haeggström JZ; Macchia L
Biochem Biophys Res Commun; 2004 Nov; 324(2):815-21. PubMed ID: 15474500
[TBL] [Abstract][Full Text] [Related]
8. [Lipoamino acids and lipopeptides as potential 5- and 12-lipoxygenase inhibitors].
Presenz P
Pharmazie; 1997 Feb; 52(2):164-5. PubMed ID: 9122277
[No Abstract] [Full Text] [Related]
9. Cell biology of the 5-lipoxygenase pathway.
Peters-Golden M
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S227-31; discussion S231-2, S247-8. PubMed ID: 9647604
[TBL] [Abstract][Full Text] [Related]
10. Eugenol--the active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells.
Raghavenra H; Diwakr BT; Lokesh BR; Naidu KA
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):23-7. PubMed ID: 16216483
[TBL] [Abstract][Full Text] [Related]
11. Lipoxygenase inhibitors from natural plant sources. Part 2: medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists.
Schneider I; Bucar F
Phytother Res; 2005 Apr; 19(4):263-72. PubMed ID: 16041764
[TBL] [Abstract][Full Text] [Related]
12. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.
Sparrow CP; Olszewski J
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):128-31. PubMed ID: 1729678
[TBL] [Abstract][Full Text] [Related]
13. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.
Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707
[TBL] [Abstract][Full Text] [Related]
14. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
Delorme D; Ducharme Y; Brideau C; Chan CC; Chauret N; Desmarais S; Dubé D; Falgueyret JP; Fortin R; Guay J; Hamel P; Jones TR; Lépine C; Li C; McAuliffe M; McFarlane CS; Nicoll-Griffith DA; Riendeau D; Yergey JA; Girard Y
J Med Chem; 1996 Sep; 39(20):3951-70. PubMed ID: 8831761
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors.
Song H; Oh SR; Lee HK; Han G; Kim JH; Chang HW; Doh KE; Rhee HK; Choo HY
Bioorg Med Chem; 2010 Nov; 18(21):7580-5. PubMed ID: 20870413
[TBL] [Abstract][Full Text] [Related]
16. [Effect of exogenous leukotrienes and lipoxygenase inhibitors on apoptosis and necrosis in cultured rat hepatocytes].
Korniĭchuk HM; Makohon NV; Aleksieieva IM; Lushnikova IV
Fiziol Zh (1994); 2002; 48(3):34-40. PubMed ID: 12125283
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of malotilate on 5-, 12- and 15-lipoxygenase in human ascites cells.
Zijlstra FJ; Wilson JH; Vermeer MA; Ouwendijk RJ; Vincent JE
Eur J Pharmacol; 1989 Jan; 159(3):291-5. PubMed ID: 2537738
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
[TBL] [Abstract][Full Text] [Related]
20. The role of lipoxygenase-isoforms in atherogenesis.
Kühn H; Römisch I; Belkner J
Mol Nutr Food Res; 2005 Nov; 49(11):1014-29. PubMed ID: 16270276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
